Stay updated on Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.3 on the page's document section, indicating an updated version of the study materials.
    Difference
    0.0%
    Check dated 2026-06-30T00:55:37.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Recruitment status on the study page now indicates enrollment is closed, signaling that new participants cannot join. Additional changes include the addition of help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and an updated revision note (Revision: v3.6.0), while the old 'Intervention / Treatment' label and the prior revision text were removed.
    Difference
    0.4%
    Check dated 2026-06-15T18:06:28.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.5.4 to v3.5.5, representing a small system version update for the page and suggesting no change to the study information.
    Difference
    0.0%
    Check dated 2026-06-08T16:53:33.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4. This indicates a newer page version and potential updates to the documentation or content.
    Difference
    0.0%
    Check dated 2026-05-18T03:56:16.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    This updates the website’s displayed revision/version number from v3.5.0 to v3.5.3, reflecting a documentation or platform release rather than any change to the clinical trial content.
    Difference
    0.0%
    Check dated 2026-04-26T15:26:20.000Z thumbnail image
  8. Check
    107 days ago
    Change Detected
    Summary
    Added posted results data including incidence of dose-limiting toxicities, 18-month overall survival, and adverse events with time-to-event endpoints, and updated results reporting dates. Linked or updated study documents (protocol/consent forms) accompany the results.
    Difference
    2%
    Check dated 2026-03-29T00:31:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.